SCHEMBL13554137

SCHEMBL13554137

c1ccc(-c2nc(-c3ccc4c(c3)c3ccccc3n4-c3ccccc3)cc(-c3ccc4c(c3)c3ccccc3n4-c3ccccc3)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
ATM Q13315 1/20 0.53
KMT2A Q03164 9/20 0.45
MEN1 O00255 8/20 0.45
ALDH1A1 P00352 6/20 0.45
MAPT P10636 6/20 0.45
HPGD P15428 5/20 0.45
NTSR1 P30989 1/20 0.45
LMNA P02545 2/20 0.43
GLA P06280 1/20 0.43
PTGER4 P35408 1/20 0.43
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
PTGES O14684 1/20 0.38
IL1R1 P14778 1/20 0.38
NPY5R Q15761 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15394914 0.99 KDM4E (0.51) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL13554138 0.99 KDM4E (0.51) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL20251576 0.97 KDM4E (0.50) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL15395012 0.96 KDM4E (0.51) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL13554140 0.95 KDM4E (0.55) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL15394778 0.95 KDM4E (0.47) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL18213954 0.95 KDM4E (0.47) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL20251557 0.95 KDM4E (0.47) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL20251551 0.95 KDM4E (0.47) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL18213898 0.95 KDM4E (0.47) KDM4EL3MBTL1ATMKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120267620-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE ORGANIC PHOTOELECTRIC DEVICE CHEIL INDUSTRIES, INC. (KR) 2012-10-25 US disclosed
US-20120267620-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE ORGANIC PHOTOELECTRIC DEVICE CHEIL INDUSTRIES, INC. (KR) 2012-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120267620-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE ORGANIC PHOTOELECTRIC DEVICE PPOX, AOX1, PNPO KDM4E 1649/4885L3MBTL1 4094/4885ATM 3669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.